# Food and Relative Bioavailability Study

> **NCT00843011** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 14 (actual)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** Orvepitant

## Key facts

- **NCT ID:** NCT00843011
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-28
- **Primary completion:** 2008-10-23
- **Final completion:** 2008-10-23
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00843011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00843011, "Food and Relative Bioavailability Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00843011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*